TheAnswerPage

JANUARY 11, 2022

Well, if your answer is ‘no,’ you are definitely not alone. Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). Are you able to answer your patients’ medical marijuana questions?

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming.

History 119

History Microdosing Research and Development Clinical Trials 119

SpeedWeed

AUGUST 4, 2021

After watching my brother self-medicate for his chronic pain for decades, I didn’t understand how cannabis was important to him as a medicine. in 2014, I watched my brother walk into a cannabis clinic. It had a dispensary out the front, and the doctors prescribing the medicines were out the back. During a social trip to the U.S.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Medical Cannabis Seedbank

FEBRUARY 26, 2018

Unfortunately, many of those victims are either unaware or simply have not been given the option of alternative treatments to the more orthodox chemotherapy. The alternative treatment that we will focus on in this post is the use of medical cannabis and its healing qualities. Countries such as the U.S.A Encourage appetite.

Treatment 63

Treatment Patients Clinical Trials THC 63

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Removing cannabis from the CSA, a/k/a descheduling, would not amend its legal definition in such a way that it would meet either requirement.

Business 52

Business Policy Clinical Trials Research and Development 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 24, 2019

321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body. March 25, 2019 posting – “CBD is being adopted more and more as a natural alternative to pharmaceutical-grade treatments for depression and anxiety.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

CannaMD

AUGUST 8, 2020

Hemp is often used in manufacturing; whereas marijuana serves a primarily medicinal/recreational purpose. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD. One more difference? For more information, see: What Is Hemp & Why Does It Matter?

CBD 99

CBD DEA Research and Development Hemp 99

The Joint Blog

JULY 25, 2020

FDA-approval on CBD Despite the rapid growth of the CBD market, there is only one FDA-approved CBD product in the United States to this day – a prescription medicine called Epidiolex that is used for treating seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in kids. In addition, 15 of the 31 products (48%) contained THC.

CBD 33

CBD Clinical Trials Safety Media 33

Greencamp

AUGUST 16, 2018

Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression.

Therapy 52

Therapy Research and Development Business Access 52

Greencamp

FEBRUARY 2, 2019

Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). Cannabis as medicine against HIV. How classical pharmaceuticals fight HIV.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Info

OCTOBER 11, 2019

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary. One such circumstance is a clinical trial.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Project CBD

MAY 3, 2023

She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Remember, the pharmaceutical model is “this medicine addresses this specific target.”

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. National Library of Medicine website. Epilepsy Behav. 2022;127:108514. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

APRIL 18, 2022

F or example, the study reports a definitive correlation between accelerated aging and lifetime cannabis use. The researchers conducted a study on mice and found that they were “able to regress to the state of two-month-old mice with a prolonged low-dose treatment with a cannabis active ingredient.” . The Final Verdict.

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care.

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Cannabis Law Report

DECEMBER 20, 2021

Conventionally, hemp in India was used for preparing natural medicines, nutritional foods and also fibre to make textiles. Finally the definition of cannabis included ‘ flowering or fruiting tops (excluding seeds and leaves when not accompanied by tops ) from which resin is not extracted ‘ 4.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Cannabis Law Report

OCTOBER 3, 2019

Final Report Reviewing Framework for Medicinal Cannabis Cultivation, Production and Manufacture. Professor John McMillan AO’s review was conducted on the extensive amendments made to the ND Act in 2016, which established a regime for the cultivation, production and manufacture of medicinal cannabis in Australia. Key findings.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care.

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

CannaMD

MARCH 8, 2020

The study touched on a number of both general and specific concerns related to marijuana’s potential role in a range of cardiovascular disorders, but ultimately offered no specific and definitive conclusions. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Cannabis Law Report

SEPTEMBER 21, 2021

Oregon has, as we know, been through all the trials and tribulations that many other states are going through now with regard to licensing and building both a self-sustaining and sustainable cannabis sector. Do you think 6 years in these monikers still apply as a legal definition of a cannabis production or retail business? .

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MARCH 12, 2021

You go back to kind of the 1800s, and this is with the germ theory of disease, and this is with trying to standardize and legitimize the practice of medicine. There’s a huge attempt by the industry, especially during the late 1800s, early to mid-1900s, to legitimize the practice of medicine. It’s germs that cause disease.”

Legalization 128

Legalization Patients Education Dispensary 128

The Cannigma

FEBRUARY 11, 2021

There was definitely no way of ensuring that you got the same effect from it consistently. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I Back in those days there was really no lab tested medicine at the dispensaries. I know how to collect data. Why cannabis?

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

CannaMD

OCTOBER 7, 2019

Also of interest, The American Journal of Medicine adds: We found significant associations between marijuana use and smaller waist circumferences. While scientists are still searching for a definitive explanation, researchers with Cannabis and Cannabinoid Research have an interesting theory. What About the “Munchies”?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

The Cannigma

DECEMBER 22, 2021

EG: Yeah, definitely. It’s actually making decisions, what is the definition of the product? We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. They have what they call a herbal medicine.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

The Cannigma

MAY 7, 2021

This is where the crux of the issue is, if you are a patient then you have epilepsy or your child has epilepsy, you want a qualified product that you can rely on that has the same level of provision in relation to the manufacturing process as any other medicine that you would take. MSO: Let’s pivot for a minute.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

OCTOBER 17, 2019

Plants with a level of THC content low enough that they are considered non-intoxicating—with the specific definitions varying depending on the jurisdiction—are classified as industrial hemp. They don’t want to disallow access to the only thing that may stop epileptic seizures in children or is part of a patient’s treatment plan.”

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JUNE 30, 2019

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. The panel also took up a bill sponsored by Rep. Illinois J.B.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40